- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00717912
Determination of the Glycemic Index and the Insulinemic Index of a Sweetener Syrup
Determination of the Glycemic Index and the Insulinemic Index of a Sweetener
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Glycemic index is a measure of how carbohydrate-containing foods affect blood glucose levels. All foods that contain carbohydrates, such as starchy vegetables (potatoes, corn), desserts, fruits, bread, pasta, and rice, can be tested for how they affect blood sugar levels after being eaten. Glycemic index is assessed by having one or more people eat a specific amount of a single food (usually 50 grams of digestible carbohydrate) and then measuring the change in blood sugar levels compared with the levels achieved after they have eaten a control food containing the same amount of digestible carbohydrate, such as white bread or glucose. The average change in blood sugar levels over a set period of time relative to the levels after consumption of the control food, usually white bread or glucose, is the food's glycemic index.
Insulinemic index is measure with the same methodology.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nantes, France, 44200
- Biofortis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 18-50 years
- male
- healthy volunteers
- BMI above 25 kg/m²
Exclusion Criteria:
- no medical history of hypercholesterolemia, high pressure blood, diabetes, sugar intolerance
- food allergy
- kidney deficiency
- liver troubles
- gastro-intestinal troubles
- drugs which impair sugar and lipid metabolism
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm 1
Classical sugar syrup / Classical sweetener syrup / Classical sugar syrup / Experimental sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup
|
3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber
1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber
3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber
|
Experimental: Arm 2
Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sugar syrup / Classical sweetener syrup / Classical sugar syrup / Experimental sweetener syrup
|
3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber
1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber
3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber
|
Experimental: Arm 3
Experimental sweetener syrup / Classical sugar syrup / Experimental sweetener syrup / Classical sweetener syrup / Classical sugar syrup / Classical sugar syrup / Experimental sweetener syrup
|
3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber
1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber
3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber
|
Experimental: Arm 4
Experimental sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sugar syrup / Classical sugar syrup / Classical sweetener syrup
|
3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber
1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber
3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber
|
Experimental: Arm 5
Classical sugar syrup / Experimental sweetener syrup / Classical sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sugar syrup
|
3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber
1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber
3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber
|
Experimental: Arm 6
Experimental sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sweetener syrup / Classical sugar syrup / Classical sugar syrup
|
3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber
1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber
3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemic Index
Time Frame: Every 48 hours (each new intervention), over a 2 hour blood glucose challenge
|
The specific measure that will be use to determine the glycemic responses is the change in blood sugar levels compared with the levels achieved after they have eaten a control food containing the same amount of digestible carbohydrate. Sugar syrup was used as the reference food, giving it a glycemic index value of 100 by definition. The AUC of the test food is divided by the AUC of the standard (glucose) and multiplied by 100. Low GI: 55 or less, Medium GI: 56-69, High GI: 70 and above |
Every 48 hours (each new intervention), over a 2 hour blood glucose challenge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insulinemic Index
Time Frame: Every 48 hours (each new intervention), over a 2 hour blood glucose challenge
|
The specific measure that will be use to determine the insulinemic responses is the change in blood insuline levels compared with the levels achieved after they have eaten a control food containing the same amount of digestible carbohydrate. Sugar syrup was used as the reference food, giving it a insulinemic index value of 100 by definition. The AUC of the test food is divided by the AUC of the standard (glucose) and multiplied by 100. Low GI: 55 or less, Medium GI: 56-69, High GI: 70 and above |
Every 48 hours (each new intervention), over a 2 hour blood glucose challenge
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jean-Marc Cazaubiel, Doctor, Biofortis
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SIRODEX 9708
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
PMV Pharmaceuticals, IncRecruitingHealthy VolunteersUnited States
Clinical Trials on Experimental sweetener syrup
-
University of California, DavisNational Heart, Lung, and Blood Institute (NHLBI); University of Southern California and other collaboratorsCompletedObesity | Type 2 Diabetes | Chronic Disease of Cardiovascular SystemUnited States
-
University of California, DavisNational Heart, Lung, and Blood Institute (NHLBI)CompletedMetabolic Syndrome | Insulin Resistance | DyslipidemiaUnited States
-
CargillCompleted
-
University of TorontoCanadian Institutes of Health Research (CIHR)CompletedObesity PreventionCanada
-
University of TorontoCanadian Institutes of Health Research (CIHR)CompletedHealthy Boys With no Emotional, Behavioral or Learning Problems Within a Normal Body WeightCanada
-
Chulalongkorn UniversityUnknown
-
George Washington UniversityChildren's National Research InstituteActive, not recruitingType 1 DiabetesUnited States
-
Brooke Army Medical CenterThe Geneva FoundationCompleted
-
Penn State UniversityZarbee's Inc.Completed
-
Jessica RiguttoUniversity of Oxford; Jomo Kenyatta University of Agriculture and Technology... and other collaboratorsCompletedIron-deficiency | Iron Deficiency Anemia | Pediatric ALL | VaccinationKenya, Switzerland